Article info
PDFPancreas
Original article
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
- Correspondence to Dr Travis S Young, California Institute for Biomedical Research, USA; tyoung{at}calibr.org, Dr Alexandra Aicher, Barts Cancer Institute, Queen Mary University of London, UK; aicher_a{at}yahoo.com and Dr Christopher Heeschen, Adult Cancer Program, Lowy Cancer Research Centre, Sydney NSW 2052, Australia; christopher.heeschen{at}icloud.com
Citation
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Publication history
- Received April 8, 2018
- Revised July 12, 2018
- Accepted July 13, 2018
- First published August 18, 2018.
Online issue publication
March 28, 2020
Article Versions
- Previous version (8 May 2019).
- Previous version (8 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.